Alerts will be sent to your verified email
Verify Email
RGIL
|
Rotographics (India)
|
Cerebra Integ. Tech
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.04 % | -1.34 % | 0.21 % |
|
5yr average Equity Multiplier
|
1.03 | 1.52 | 1.01 |
|
5yr Average Asset Turnover Ratio
|
0.05 | 0.3 | 0.02 |
|
5yr Avg Net Profit Margin
|
4.84 % | -13.9 % | -19.83 % |
|
Price to Book
|
20.23 | 0.5 | 0.89 |
|
P/E
|
730.36 | 0.0 | 67.71 |
|
5yr Avg Cash Conversion Cycle
|
-29.67 Days | 765.04 Days | 0.0 |
|
Inventory Days
|
0.0 | 113.07 Days | 0.0 |
|
Days Receivable
|
0.0 | 916.46 Days | 0.0 |
|
Days Payable
|
246.4 Days | 375.27 Days | 1109.22 Days |
|
5yr Average Interest Coverage Ratio
|
132.75 | 1.54 | 902.8 |
|
5yr Avg ROCE
|
0.06 % | 3.66 % | 0.21 % |
|
5yr Avg Operating Profit Margin
|
-13.02 % | -2.53 % | -19.88 % |
|
5 yr average Debt to Equity
|
0.01 | 0.11 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
-0.04 % | -0.8 % | 0.21 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
13.99 % | 0.84 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-37.11 % | -4.21 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rotographics (India)
|
Cerebra Integ. Tech
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|